232 related articles for article (PubMed ID: 23324778)
1. Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases.
Duong TA; Haddad C; Valeyrie-Allanore L; Sbidian E; Chosidow O; Wolkenstein P
JAMA Dermatol; 2013 Jan; 149(1):113-5. PubMed ID: 23324778
[No Abstract] [Full Text] [Related]
2. Toxic epidermal necrolysis with isolated neutropenia related to the use of levetiracetam.
Oh SJ; Kwon HI; Moon SH; Ro YS; Ko JY
J Dermatol; 2016 Aug; 43(8):969-71. PubMed ID: 26893076
[No Abstract] [Full Text] [Related]
3. Toxic epidermal necrolysis associated with the use of levetiracetam.
Sierra-Gordillo Y; Peñaranda-Contreras E; Gomez Arbeláez MM; Moreno-Lucero PA
Clin Toxicol (Phila); 2024 Mar; 62(3):201-202. PubMed ID: 38619013
[No Abstract] [Full Text] [Related]
4. Stevens-Johnson syndrome induced by levetiracetam.
Zou LP; Ding CH; Song ZJ; Li XF
Seizure; 2012 Dec; 21(10):823-5. PubMed ID: 23036769
[No Abstract] [Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
7. A topical matter: toxic epidermal necrolysis.
Ladizinski B; Sankey C
Am J Med; 2014 Oct; 127(10):931-2. PubMed ID: 24950488
[No Abstract] [Full Text] [Related]
8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
9. [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
Wolkenstein P
Therapie; 1996; 51(5):500-1. PubMed ID: 9138383
[No Abstract] [Full Text] [Related]
10. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
[No Abstract] [Full Text] [Related]
11. Toxic epidermal necrolysis triggered by clobazam: a case report in a 13-year-old girl.
Dang CD; Beets-Shay L; Kahn EC
Pediatr Dermatol; 2015; 32(3):e102-3. PubMed ID: 25690725
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
Rijal A; Agrawal S
Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
[No Abstract] [Full Text] [Related]
13. Stevens Johnson syndrome/toxic epidermal necrolysis-overlap, induced by lacosamide.
Kardaun SH; Vos BJ; Chandran NS
Eur J Dermatol; 2016 Apr; 26(2):185-6. PubMed ID: 27017922
[No Abstract] [Full Text] [Related]
14. Dose-related levetiracetam-induced reticulated drug eruption.
Beswick TC; Cohen JB
J Drugs Dermatol; 2010 Apr; 9(4):409-10. PubMed ID: 20514803
[TBL] [Abstract][Full Text] [Related]
15. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.
Yeung CK; Ma SY; Hon C; Peiris M; Chan HH
Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151
[TBL] [Abstract][Full Text] [Related]
16. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
Guleria VS; Sharda C; Rana T; Sood AK
Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
[TBL] [Abstract][Full Text] [Related]
17. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
[TBL] [Abstract][Full Text] [Related]
18. [Lamotrigine and its relationship with Stevens-Johnson syndrome and toxic epidermal necrolysis].
Velázquez-Cárcamo EA; Rodríguez-Chávez Y; Méndez-Flores S; Domínguez-Cherit J
Rev Med Inst Mex Seguro Soc; 2020 Apr; 58(2):202-205. PubMed ID: 34101565
[TBL] [Abstract][Full Text] [Related]
19. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine and toxic epidermal necrolysis.
Wadelius M; Karlsson T; Wadelius C; Rane A
Lancet; 1996 Oct; 348(9033):1041. PubMed ID: 8855897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
